Protalix BioTherapeutics, Inc.

AMEX (USD): Protalix BioTherapeutics, Inc. (PLX)

Last Price

1.83

Today's Change

+0.05 (2.80%)

Day's Change

1.74 - 1.83

Trading Volume

271,807

Technical Analysis

Technical analysis is a means of examining and predicting price movements in the financial markets, by using historical price charts and market statistics.

Popular technical indicators such as moving averages, relative strength index, William R%, Money Flow Index, Percentage Price Oscillator, Moving Average Convergence-Divergence and Stochastic Oscillator are used to analyze the trend, momentum and strength of a stock.

Simple Moving Average

Name

Value

Variance

SMA10

4.444

-0.344 | -8%

SMA10

4.444

-0.344 | -8%

SMA10

4.444

-0.344 | -8%

SMA10

4.444

-0.344 | -8%

SMA10

4.444

-0.344 | -8%

SMA10

4.444

-0.344 | -8%

SMA10

4.444

-0.344 | -8%

SMA10

4.444

-0.344 | -8%

SMA10

4.444

-0.344 | -8%

SMA10

4.444

-0.344 | -8%

Exponential Moving Average

Name

Value

Variance

EMA10

4.372

-0.272 | -6%

EMA10

4.372

-0.272 | -6%

EMA10

4.372

-0.272 | -6%

EMA10

4.372

-0.272 | -6%

EMA10

4.372

-0.272 | -6%

EMA10

4.372

-0.272 | -6%

EMA10

4.372

-0.272 | -6%

EMA10

4.372

-0.272 | -6%

EMA10

4.372

-0.272 | -6%

EMA10

4.372

-0.272 | -6%

Relative Strength Index

Name

Value

RSI 9

6.604

RSI 9

6.604

RSI 9

6.604

Percentage Price Oscillator

Name

PPO

Signal

Variance

5,35,5

-12.07

-10.37

-1.70 | -16%

5,35,5

-12.07

-10.37

-1.70 | -16%

William %R

Name

Value

%R-9

-88.496%

%R-9

-88.496%

%R-9

-88.496%

Moving Average Convergence-Divergence

Name

PPO

Signal

Variance

5,35,5

-12.07

-10.37

-1.70 | -16%

5,35,5

-12.07

-10.37

-1.70 | -16%

Money Flow Index

Name

Value

MFI-9

6.348

MFI-9

6.348

MFI-9

6.348

Stochastic Oscillator

%K (Fast)

6.348

%K (Fast)

6.348

%K (Fast)

6.348

%K (Fast)

6.348

Rate of Change

Name

Value

MFI-21

29.833

MFI-21

29.833

MFI-21

29.833

MFI-21

29.833

Discussions
Be the first to like this. Showing 3 of 3 comments

ysabag

with the new ceo it will raise above the target

2014-07-29 14:51

Tygobar

Yes, medical startups usually should very very good in everything like that really and totally , yet you do have very low price of the stock here, how can you really even describe this ? Could you damn let me know this please. I am all ears for example.

2019-09-01 13:12

Lalis

I do hope that medical things will be really our future and not just cause it cause something for example good for now, but in the real perspective for many many generations ahead totally. But for now of course I plan to invest a lot in such things.

2019-09-07 13:56

Post a Comment